Proteomic analysis of extracellular matrix from the hepatic stellate cell line LX-2 identifies CYR61 and Wnt-5a as novel constituents of fibrotic liver | Journal of Proteome Research
Biomedicines | Free Full-Text | Hepatic Stellate Cell Activation and Inactivation in NASH-Fibrosis—Roles as Putative Treatment Targets?
Serum markers of liver fibrosis
Frontiers | Immunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment
Extracellular Matrix Remodeling in Chronic Liver Disease | SpringerLink
Hep3Gel: A Shape-Shifting Extracellular Matrix-Based, Three-Dimensional Liver Model Adaptable to Different Culture Systems | ACS Biomaterials Science & Engineering
Extracellular matrix and its therapeutic potential for cancer treatment | Signal Transduction and Targeted Therapy
Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease - ScienceDirect